Global Blood Profile

32.3
USD 0.6  1.82%
28.15Last Month High 33.2 
31.95Trading Day  High 33.7 

Global Blood exotic insider transaction detected

Global Blood Therapeutics Inc insider trading alert for general transaction of common stock by Charles Homcy, the corporate stakeholder, on October 5, 2017. This event was filed by Global Blood Therapeutics with SEC on 2017-10-05. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Global Blood Summary

Global Blood Therapeutics Inc (GBT) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 55 people. Global Blood is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mid-Cap' category with total capitalization of 1.44 B. Global Blood Therapeutics Inc runs under Healthcare sector within Biotechnology industry. This company has 43.76 M outstanding shares of which 5.45 M shares are currently shorted by investors with about 8.98 days to cover shorted positions. ADVANCED BATTERY has about 229.82 M in cash with (80.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.26.
Check Global Blood Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Selected Global Blood Therapeutics Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Global Blood Against Markets

Risk Adjusted
Performance Score (0 to 100)
17 
Chance of
< 40% 
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics to treat grievous bloodbased disorders. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameGlobal Blood Therapeutics Inc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
RegionNorth America
LocationCALIFORNIA, U.S.A
Business AddressGlobal Blood Therapeutics, Inc.South San Francisco, CA
Foreign Associate  Germany
ExchangeNASDAQ
CIK Number01629137.0
CUSIP37890U108
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitewww.globalbloodtx.com
Contact Number650 741 7700
CurrencyUSD - US Dollar

Recommendations

Global Blood Analyst Recommendations
Target PriceAdvice# of Analysts
57.2Buy5Odds
Global Blood Therapeutics Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Global Blood Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Earnings

Global Blood Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.64April 4, 2017
Global Blood Therapeutics Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate